IMBRIA

Welcome to the Brand page for “IMBRIA”, which is offered here for Pharmaceuticals for treatment of mitochondrial disorders, genetic diseases, cardiovascular diseases, neurological diseases, renal diseases, and blood diseases;.

Its status is currently believed to be active. Its class is unavailable. “IMBRIA” is believed to be currently owned by “Imbria Pharmaceuticals, Inc.”


Owner:
IMBRIA PHARMACEUTICALS, INC.
Owner Details
Description:
Pharmaceuticals for treatment of mitochondrial disorders, genetic diseases, cardiovascular diseases, neurological diseases, renal diseases, and blood diseases;
Categories: PHARMACEUTICALS TREATMENT MITOCHONDRIAL